EAU 2020

European Association of Urology annual congress

Letter from the Editor

New urosepsis data from the SERPENS study

Pressure and temperature: do high-power lasers pose a threat?

Radiation stewardship for patient and endourologist

New lithotripter data: improved stone clearance

KEYNOTE-426: no QoL differences pembrolizumab + axitinib versus sunitinib

Debate: upfront cytoreductive nephrectomy or not?

Robotic-assisted partial nephrectomy: lower morbidity

Reduced BCG frequency, faster NMIBC recurrence

Nadofaragene firadenovec effective in BCG-unresponsive papillary NMIBC

Understanding MIBC biology for novel treatment options

Prostatectomy: R-LRPE better than LRPE for continence

PSMA PET-CT staging is 27% more accurate

Docetaxel + hormonal therapy: improved prostate cancer PFS

ARAMIS subgroup analysis: darolutamide benefits across PSADT groups

Large patient-driven survey reveals QoL issues after prostate cancer treatment

Targeting steroid sulphatase in resistant prostate cancer cells

Good tolerance of post-RP radiotherapy ± short term ADT

LUTS 2-year outcomes: aquablation versus TURP

HoLEP versus PVP in prospective randomised trial

LUTS in the neuro-urologic patient

Peyronie's disease: surgical options

Infertility and testis cancer risk: causal or association?

32% more men complain of reduced sex drive in 2019 versus 2009

The content and interpretation of these conference highlights are the views and comments of the speakers/ authors.